Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.85% | -14.69% | -19.11% | -34.34% | -26.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.85% | -14.69% | -19.11% | -34.34% | -26.32% |
| Cost of Revenue | -34.05% | -50.90% | -37.10% | -29.98% | -12.12% |
| Gross Profit | 77.28% | 38.88% | 9.30% | -50.37% | -44.99% |
| SG&A Expenses | -13.65% | -11.26% | 2.64% | 1.34% | 69.06% |
| Depreciation & Amortization | -13.87% | -14.58% | -13.60% | -60.54% | 291.35% |
| Other Operating Expenses | 69.07% | 13.28% | -41.60% | -112.60% | 53.04% |
| Total Operating Expenses | -10.93% | -26.05% | -20.81% | -27.87% | 26.49% |
| Operating Income | 27.30% | 53.25% | 25.72% | 20.70% | -1,455.92% |
| Income Before Tax | -8.10% | 12.04% | 3.03% | -104.26% | -556.31% |
| Income Tax Expenses | -130.43% | 9.09% | -- | -- | -- |
| Earnings from Continuing Operations | -7.99% | 12.03% | 2.91% | -104.32% | -556.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -45.07% | -81.48% | -- | -- | -- |
| Net Income | -8.06% | 11.90% | 2.61% | -103.94% | -556.01% |
| EBIT | 27.30% | 53.25% | 25.72% | 20.70% | -1,455.92% |
| EBITDA | 29.03% | 60.60% | 28.86% | 15.69% | -2,423.17% |
| EPS Basic | -1.93% | 16.95% | 6.53% | -107.26% | -532.22% |
| Normalized Basic EPS | 0.85% | 16.93% | 6.82% | 23.74% | -522.81% |
| EPS Diluted | 0.00% | 16.95% | 17.75% | -115.38% | -500.00% |
| Normalized Diluted EPS | 0.85% | 16.93% | 6.82% | 23.74% | -522.81% |
| Average Basic Shares Outstanding | 5.90% | 6.09% | 4.47% | -1.64% | 4.29% |
| Average Diluted Shares Outstanding | 5.90% | 6.09% | 4.47% | -1.64% | 4.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |